Document is current
Any future updates will be listed below
-
Authors
Weaver, James
Voss, Erica A.
Cafri, Guy
Beyrau, Kathleen
Nashleanas, Michelle
Suruki, Robert
-
Funding
Funding for this research was provided by:
Johnson and Johnson
- License Information
-
More Information
Article History
Received: 4 December 2023
Accepted: 27 November 2024
First Online: 27 December 2024
Declarations
:
: The New England Institutional Review Board (IRB) determined that studies conducted in CCAE, Clinformatics<sup>®</sup>, and Optum<sup>®</sup> EHR are exempt from study-specific IRB review, as these do not qualify as human subject research. For Pharmetrics and Amb EMR, patient permission was not required because all patient data were de-identified for research purposes.
: Not applicable.
: JW, EAV, and RS are employees of Janssen Research and Development LLC (A Johnson & Johnson company). MN are employees Johnson & Johnson. GF is an employee of Johnson & Johnson MedTech. KB was an employee of Johnson & Johnson at the time of this work and is now retired. All are shareholders of Johnson & Johnson.
